Open Access

ESC-HF guidelines for management of MR and TR: the update and its clinical implications.

Congress Session

About the speakers

Professor Jeroen Bax

Leiden University Medical Center, Leiden (Netherlands (The))
66 presentations
1 follower

Professor Ralph Stephan Von Bardeleben

University Medical Center of Mainz, Mainz (Germany)
53 presentations
1 follower

Professor Michael Boehm

Saarland University Hospital, Homburg (Germany)
57 presentations
0 follower

4 more presentations in this session

Session opening​.

Speaker: Professor J. Bax (Leiden, NL)

Thumbnail

Supporting HF treatment through transcatheter valve therapy​.

Speaker: Professor M. Boehm (Homburg, DE)

Thumbnail

Successful treatment of MR and TR patients​ with differentiated transcatheter technologies.

Speaker: Professor R. Von Bardeleben (Mainz, DE)

Thumbnail

Session evaluation and key learnings​.

Speaker: Professor J. Bax (Leiden, NL)

Thumbnail

Access the full session

Transcatheter options for the management of HF patients with MR or TR: the new ESC-HF and ESC/EACTS VHD guidelines

Speakers: Professor J. Bax, Professor R. Von Bardeleben, Professor M. Boehm, Professor J. Bax, Professor M. Boehm...
Thumbnail

About the event

Image

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

Sessions Presentations

Related content

ESC Premium Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: how to implement the guidelines and take-home message.

27 August 2021

ESC Premium Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: what do the guidelines say?

27 August 2021

ESC Premium Access

An asymptomatic patient with positive treadmill test during screening for life insurance and significant proximal LAD disease in coronary CT angiography: case presentation.

27 August 2021

This platform is supported by

logo Novo Nordisk